Related Experiment Video
Updated: May 17, 2025
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Inorganic Arsenic Induces Elevated p53 Levels with Altered Functionality Impacting the Expression of Toll-like
Nancy C Pacheco-Castillo1, Jesús Gómez-Montalvo2, Vanesa Olivares-Illana3
1Laboratorio de Inmunotoxicología, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí 78210, Mexico.
Abstract:
Prostate cancer (PCa) is a major global health concern, particularly in advanced stages where chemotherapy resistance and androgen-independent tumor growth reduce survival rates to below 30%. Toll-like receptor 3 (TLR3), regulated by tumor suppressor p53, is a promising therapeutic target due to its role in tumor cell apoptosis. However, chronic exposure to inorganic arsenic (iAs), a known carcinogen, has been linked to PCa progression and reduced TLR3 expression and activation by polyinosinic/polycytidylic acid (Poly(I/C)), a synthetic ligand used in PCa immunotherapy. Here, we demonstrate that chronic sodium arsenite (NaAsO) exposure increases p53 transcript and protein levels in immortalized prostate epithelial cells. Despite this, key p53 target genes, including TLR3, CDKN1A, and BAX, were significantly downregulated, indicating a transcriptionally inactive p53. Chromatin immunoprecipitation (ChIP) confirmed diminished p53 binding to TLR3 and CDKN1A promoters, while sequencing ruled out TP53 mutations. A bioinformatic analysis revealed elevated TP53 but reduced TLR3 and CDKN1A in prostate adenocarcinoma, suggesting that iAs-induced oxidative stress disrupts p53 function. These findings reveal a novel mechanism by which iAs promotes PCa progression through impaired p53 activity, highlighting the need to explore post-translational and epigenetic factors affecting p53. Restoring p53 transcriptional activity may offer a therapeutic strategy for PCa patients exposed to NaAsO.
Insights
Inorganic arsenic exposure impairs tumor suppressor p53 function in prostate cancer (PCa) cells, leading to reduced expression of key genes like Toll-like receptor 3 (TLR3). This mechanism promotes PCa progression and suggests therapeutic strategies targeting p53 activity.
Area of Science:
- Oncology
- Environmental Health
- Molecular Biology
Background:
- Prostate cancer (PCa) poses a significant global health challenge, especially in advanced stages.
- Chemotherapy resistance and androgen-independent growth limit survival rates in advanced PCa.
- Toll-like receptor 3 (TLR3), regulated by p53, is a potential therapeutic target for PCa.
- Inorganic arsenic (iAs) exposure is linked to PCa progression and reduced TLR3 expression.
Purpose of the Study:
- Investigate the impact of chronic inorganic arsenic exposure on p53 function in prostate epithelial cells.
- Determine the mechanism by which iAs affects p53 transcriptional activity and downstream target genes.
- Explore the role of impaired p53 activity in iAs-induced PCa progression.
Main Methods:
- Chronic sodium arsenite (NaAsO) exposure of immortalized prostate epithelial cells.
- Analysis of p53, TLR3, CDKN1A, and BAX gene and protein expression.
- Chromatin immunoprecipitation (ChIP) to assess p53 promoter binding.
- TP53 mutation analysis via sequencing.
- Bioinformatic analysis of TP53, TLR3, and CDKN1A in prostate adenocarcinoma data.
Main Results:
- Chronic NaAsO exposure increased p53 transcript and protein levels but decreased expression of p53 target genes (TLR3, CDKN1A, BAX).
- p53 binding to TLR3 and CDKN1A promoters was diminished, indicating transcriptionally inactive p53.
- TP53 mutations were ruled out as the cause of p53 dysfunction.
- Bioinformatic analysis showed elevated TP53 but reduced TLR3 and CDKN1A in prostate adenocarcinoma, correlating with iAs exposure effects.
Conclusions:
- Chronic iAs exposure disrupts p53 transcriptional activity in prostate cells, likely through oxidative stress-induced post-translational or epigenetic modifications.
- Impaired p53 function contributes to PCa progression by downregulating tumor suppressor genes like TLR3.
- Restoring p53 transcriptional activity represents a potential therapeutic strategy for PCa patients with iAs exposure.
Related Concept Videos
02:23Abnormal Proliferation
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:25Mutagenicity and Carcinogenicity